首页 > 最新文献

Medical and pediatric oncology最新文献

英文 中文
Asymmetric salivary gland 123I-meta-iodobenzylguanidine uptake in a patient with cervical neuroblastoma and Horner syndrome. 宫颈神经母细胞瘤和Horner综合征患者涎腺123i -间碘苄基胍摄取不对称。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1114
T. Simon, E. Voth, F. Berthold
{"title":"Asymmetric salivary gland 123I-meta-iodobenzylguanidine uptake in a patient with cervical neuroblastoma and Horner syndrome.","authors":"T. Simon, E. Voth, F. Berthold","doi":"10.1002/MPO.1114","DOIUrl":"https://doi.org/10.1002/MPO.1114","url":null,"abstract":"","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"5 1","pages":"489-90"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75333244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Survival trends of childhood cancer diagnosed during 1970-1994 in Piedmont, Italy: a report from the Childhood Cancer Registry. 意大利皮埃蒙特1970-1994年间诊断出的儿童癌症的生存趋势:来自儿童癌症登记处的报告。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1113
G. Pastore, M. Mosso, F. Carnevale, L. C. Montezemolo, M. Forni, E. Madon, U. Ricardi, B. Terracini, C. Magnani
BACKGROUNDThe Childhood Cancer Registry of Piedmont (CCRP) started its activity in 1967. It is population based and covers the Piedmont Region (population 4,500,000; NW Italy). This article reports on time trends in survival after a childhood cancer diagnosed during 1970-1994.PROCEDUREDuring 1970-1994, 2,329 incident cases were registered at CCRP on the basis of histological and/or clinical information, excluding 30 cases reported only by death certificate. Histological or hematological diagnosis was available for 2,067 cases. Vital status was assessed through the offices of the town of residence. At the end of follow-up, 1,202 cases were alive, 1,084 dead and 43 were not traceable. Survival was measured for the major diagnostic groups using both univariate and multivariate statistics.RESULTSThe 5-yr survival rate for acute lymphoblastic leukemia (ALL) improved regularly from 24.7% in 1970-1974 to 81.1% in 1990-1994, for acute nonlymphoblastic leukemia (ANLL) from 0% to 38.1%, for non-Hodgkin lymphoma (NHL) from 25.2% to 67.7%, for tumors of the central nervous system (CNS) (all types) from 33.4% to 75.9% and for Ewing tumor from 0% to 90%. Focusing on survival by period of diagnosis, the highest 5-year survival rate was observed for children diagnosed during 1985-1989 for medulloblastoma, neuroblastoma (NB), retinoblastoma, Wilms tumor, osteosarcoma, and rhabdomyosarcoma and for children diagnosed in 1990-1994 for the remaining sites. The trend over time was statistically significant for ALL, ANLL, NHL, CNS tumors, NB, and osteosarcoma as well as for all malignancies together.CONCLUSIONSPopulation-based survival studies are useful complements to clinical studies. Survival results in the present study are similar to those presented for other European countries and the United States. For most types of neoplasm (except CNS) survival probability appears to stabilize 5-10 years after diagnosis.
皮埃蒙特儿童癌症登记处(CCRP)于1967年开始活动。它以人口为基础,覆盖皮埃蒙特地区(人口450万;意大利西北)。这篇文章报道了1970-1994年间诊断出儿童癌症后的生存率的时间趋势。在1970-1994年期间,CCRP根据组织学和/或临床信息登记了2,329例事件病例,不包括仅通过死亡证明报告的30例病例。2067例有组织学或血液学诊断。生命状况是通过居住城镇的办事处评估的。随访结束时,1202例存活,1084例死亡,43例无法追踪。使用单变量和多变量统计来测量主要诊断组的生存率。结果急性淋巴母细胞白血病(ALL)的5年生存率从1970-1974年的24.7%提高到1990-1994年的81.1%,急性非淋巴母细胞白血病(ANLL)的5年生存率从0%提高到38.1%,非霍奇金淋巴瘤(NHL)的5年生存率从25.2%提高到67.7%,中枢神经系统肿瘤(CNS)(所有类型)的5年生存率从33.4%提高到75.9%,尤因肿瘤的5年生存率从0%提高到90%。关注诊断期的生存率,观察到1985-1989年诊断为髓母细胞瘤、神经母细胞瘤(NB)、视网膜母细胞瘤、Wilms肿瘤、骨肉瘤和横纹肌肉瘤的儿童的5年生存率最高,而1990-1994年诊断为其余部位的儿童的5年生存率最高。随着时间的推移,ALL、ANLL、NHL、CNS肿瘤、NB和骨肉瘤以及所有恶性肿瘤的趋势都具有统计学意义。结论基于人群的生存研究是临床研究的有益补充。本研究的生存结果与其他欧洲国家和美国的研究结果相似。对于大多数类型的肿瘤(中枢神经系统除外),诊断后5-10年的生存率似乎稳定。
{"title":"Survival trends of childhood cancer diagnosed during 1970-1994 in Piedmont, Italy: a report from the Childhood Cancer Registry.","authors":"G. Pastore, M. Mosso, F. Carnevale, L. C. Montezemolo, M. Forni, E. Madon, U. Ricardi, B. Terracini, C. Magnani","doi":"10.1002/MPO.1113","DOIUrl":"https://doi.org/10.1002/MPO.1113","url":null,"abstract":"BACKGROUND\u0000The Childhood Cancer Registry of Piedmont (CCRP) started its activity in 1967. It is population based and covers the Piedmont Region (population 4,500,000; NW Italy). This article reports on time trends in survival after a childhood cancer diagnosed during 1970-1994.\u0000\u0000\u0000PROCEDURE\u0000During 1970-1994, 2,329 incident cases were registered at CCRP on the basis of histological and/or clinical information, excluding 30 cases reported only by death certificate. Histological or hematological diagnosis was available for 2,067 cases. Vital status was assessed through the offices of the town of residence. At the end of follow-up, 1,202 cases were alive, 1,084 dead and 43 were not traceable. Survival was measured for the major diagnostic groups using both univariate and multivariate statistics.\u0000\u0000\u0000RESULTS\u0000The 5-yr survival rate for acute lymphoblastic leukemia (ALL) improved regularly from 24.7% in 1970-1974 to 81.1% in 1990-1994, for acute nonlymphoblastic leukemia (ANLL) from 0% to 38.1%, for non-Hodgkin lymphoma (NHL) from 25.2% to 67.7%, for tumors of the central nervous system (CNS) (all types) from 33.4% to 75.9% and for Ewing tumor from 0% to 90%. Focusing on survival by period of diagnosis, the highest 5-year survival rate was observed for children diagnosed during 1985-1989 for medulloblastoma, neuroblastoma (NB), retinoblastoma, Wilms tumor, osteosarcoma, and rhabdomyosarcoma and for children diagnosed in 1990-1994 for the remaining sites. The trend over time was statistically significant for ALL, ANLL, NHL, CNS tumors, NB, and osteosarcoma as well as for all malignancies together.\u0000\u0000\u0000CONCLUSIONS\u0000Population-based survival studies are useful complements to clinical studies. Survival results in the present study are similar to those presented for other European countries and the United States. For most types of neoplasm (except CNS) survival probability appears to stabilize 5-10 years after diagnosis.","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"284 1","pages":"481-8"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81306434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Letter to the editor: Priapism as the first sign of a pelvic tumour in a two‐and‐a‐half‐year‐old boy 致编辑的信:阴茎勃起是一个两岁半男孩盆腔肿瘤的第一个征兆
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1119
M. Krawczuk-Rybak, K. Muszyńska-Rosłan, J. Oleński, E. Leszczyńska, B. Zapolska, J. Wargocki
{"title":"Letter to the editor: Priapism as the first sign of a pelvic tumour in a two‐and‐a‐half‐year‐old boy","authors":"M. Krawczuk-Rybak, K. Muszyńska-Rosłan, J. Oleński, E. Leszczyńska, B. Zapolska, J. Wargocki","doi":"10.1002/MPO.1119","DOIUrl":"https://doi.org/10.1002/MPO.1119","url":null,"abstract":"","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"111 1","pages":"503-504"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75943890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Successful management of neonatal choriocarcinoma. 新生儿绒毛膜癌的成功治疗。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1117
J. Heath, K. Tiedemann
{"title":"Successful management of neonatal choriocarcinoma.","authors":"J. Heath, K. Tiedemann","doi":"10.1002/MPO.1117","DOIUrl":"https://doi.org/10.1002/MPO.1117","url":null,"abstract":"","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"19 1","pages":"497-9"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90766869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis. 朗格汉斯细胞组织细胞增多症患者长期随访的肺部异常。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1110
C. Bernstrand, C. Bernstrand, Kerstin Cederlund, Bengt Sandstedt, Lars Åhström, Marie Lundell, G. Dahlquist, J. Henter
BACKGROUNDIn Langerhans cell histiocytosis (LCH) pulmonary involvement, which is often initially asymptomatic, may contribute to significant morbidity and mortality. To determine the long-term prognosis, a cross-sectional study was undertaken.PROCEDUREForty-one patients with > or = 5 years follow-up after the diagnosis of LCH were interviewed and underwent physical examination, blood tests, a chest X-ray and a high-resolution CT (HRCT) of the lungs. All patients included had been referred to the Department of Pediatrics at the Karolinska Hospital in Stockholm between July 1962 and February 1990 (median follow-up 16 years). Biopsies from all patients were reviewed and confirmed to be consistent with LCH. Information on previous clinical features including treatment and the results of chest X-rays were also collected for risk factor analysis.RESULTSRadiographic abnormalities of the lungs (cysts and/or emphysema), found in 10/41 (24%) at follow-up, were classified into five groups according to the extent of the cysts. These patients had more often suffered from multisystem than from single-system disease (P = 0.01), were significantly older at diagnosis (P < 0.001), and had been more heavily treated with chemotherapy and/or radiotherapy. They were also more frequently smokers (P < 0.0001) and 7/10 (70%) had suffered lung involvement at diagnosis. At the time of diagnosis of the pulmonary involvement, 4/10 (40%) patients had respiratory symptoms, but only 2/10 (20%) had symptoms at follow-up.CONCLUSIONSTen (24%) of the 41 patients had abnormal findings on radiological examination of the lungs at long-term follow-up and seven are or had been smokers. It is of great importance that patients with LCH be informed about smoking-related pulmonary morbidity. Prolonged monitoring of the lungs for smokers and patients with known pulmonary involvement is recommended.
朗格汉斯细胞组织细胞增多症(LCH)累及肺部,最初通常无症状,可导致显著的发病率和死亡率。为了确定长期预后,进行了一项横断面研究。对41例LCH诊断后随访5年以上的患者进行访谈,并进行体格检查、血液检查、胸部x线片和肺部高分辨率CT (HRCT)检查。所有纳入的患者均于1962年7月至1990年2月期间转诊至斯德哥尔摩卡罗林斯卡医院儿科(中位随访16年)。对所有患者的活组织检查进行复查并确认与LCH一致。以前的临床特征信息,包括治疗和胸部x光结果也被收集用于危险因素分析。结果随访发现肺部影像学异常(囊肿和/或肺气肿)10/41例(24%),根据囊肿的大小分为5组。这些患者多系统疾病多于单系统疾病(P = 0.01),诊断时明显年龄较大(P < 0.001),接受化疗和/或放疗的次数较多。他们吸烟的频率也更高(P < 0.0001), 7/10(70%)在诊断时肺部受累。在诊断肺部受累时,4/10(40%)患者有呼吸道症状,但随访时只有2/10(20%)患者有症状。结论41例患者在长期随访中肺部影像学检查有异常(24%),其中7例为吸烟者或曾经吸烟者。让LCH患者了解吸烟相关的肺部疾病是非常重要的。建议对吸烟者和已知肺部受累的患者进行长期肺部监测。
{"title":"Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis.","authors":"C. Bernstrand, C. Bernstrand, Kerstin Cederlund, Bengt Sandstedt, Lars Åhström, Marie Lundell, G. Dahlquist, J. Henter","doi":"10.1002/MPO.1110","DOIUrl":"https://doi.org/10.1002/MPO.1110","url":null,"abstract":"BACKGROUND\u0000In Langerhans cell histiocytosis (LCH) pulmonary involvement, which is often initially asymptomatic, may contribute to significant morbidity and mortality. To determine the long-term prognosis, a cross-sectional study was undertaken.\u0000\u0000\u0000PROCEDURE\u0000Forty-one patients with > or = 5 years follow-up after the diagnosis of LCH were interviewed and underwent physical examination, blood tests, a chest X-ray and a high-resolution CT (HRCT) of the lungs. All patients included had been referred to the Department of Pediatrics at the Karolinska Hospital in Stockholm between July 1962 and February 1990 (median follow-up 16 years). Biopsies from all patients were reviewed and confirmed to be consistent with LCH. Information on previous clinical features including treatment and the results of chest X-rays were also collected for risk factor analysis.\u0000\u0000\u0000RESULTS\u0000Radiographic abnormalities of the lungs (cysts and/or emphysema), found in 10/41 (24%) at follow-up, were classified into five groups according to the extent of the cysts. These patients had more often suffered from multisystem than from single-system disease (P = 0.01), were significantly older at diagnosis (P < 0.001), and had been more heavily treated with chemotherapy and/or radiotherapy. They were also more frequently smokers (P < 0.0001) and 7/10 (70%) had suffered lung involvement at diagnosis. At the time of diagnosis of the pulmonary involvement, 4/10 (40%) patients had respiratory symptoms, but only 2/10 (20%) had symptoms at follow-up.\u0000\u0000\u0000CONCLUSIONS\u0000Ten (24%) of the 41 patients had abnormal findings on radiological examination of the lungs at long-term follow-up and seven are or had been smokers. It is of great importance that patients with LCH be informed about smoking-related pulmonary morbidity. Prolonged monitoring of the lungs for smokers and patients with known pulmonary involvement is recommended.","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"69 1","pages":"459-68"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84442836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 52
Molecular alterations in a case of bilateral adrenal neuroblastoma. 双侧肾上腺神经母细胞瘤1例分子改变。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1115
C. Lo Cunsolo, I. Casciano, C. Gambini, B. De Bernardi, G. Tonini, M. Romani
*Neuroblastoma, the most common extracranial solidtumor of childhood, presents heterogeneous molecularand clinical characteristics. To date few molecular studieshave been reported for multifocal neuroblastoma, a modeof presentation of this tumor that occurrs in about 2% ofthe cases and reflects the complex pathogenesis of thisneoplasm [1–3]. Herein, we report a case of bilateraladrenal synchronous neuroblastoma. Our studies revealedthe presence of molecular and cytogenetic heterogeneityand suggest that a clonal evolution might have occurredin one of the primary tumors.A 7› year-old girl was admitted in June 1995 to theGaslini Children’s Hospital (Genova, Italy) for abdom-inal pain. Ultrasonography revealed a round nonhomo-geneous adrenal mass on the right (R) and a smalleradrenal mass on the left (L). Urinary catecholamineexcretion, serum lactate dehydrogenase, and ferritinlevels were abnormally elevated. Both tumors and severallymph nodes were resected. Histopathologic and clinicalevaluation led to a diagnosis of bilateral synchronousneuroblastoma, both stroma-poor [1]. The right-sidedtumor was of the undifferentiated subtype with high MKIaccording to Shimada et al. [4]. This tumor was morpho-logically heterogeneous and presented a differentiating(R1) and an undifferentiated (R2) area. The L tumor wasof the differentiating subtype, with low MKI. Six monthsafter surgery, the tumor recurred retroperitoneally, andthe patient was treated with six cycles of chemotherapyand irradiation. Fourteen months later, multiple relapseswere detected in distant lymph nodes and in the 9th rightrib. A biopsy from a lymph nodal metastasis (M) wasavailable for molecular studies. The patient was treatedwith aggressive chemotherapy, but died of diseaseprogression in 1997.Histopathologic data suggested that the R1, R2, and Ltumor areas had different biologic characteristics. In fact,immunohistochemical analysis showed a high level ofexpression of the proliferation marker Ki-67 in R2. Onthe contrary, in R1 and L an intermediate and a lownumber of cells were positive for Ki-67 (Fig. 1, A–C).The DNA index was 1.00 in all three areas. Comparativegenomic hybridization (CGH) and fluorescent in situhybridization (FISH) showed an additional copy ofchromosome 7 in R1, R2, and M, but not in L (Fig. 1,D–I). MYCN gene amplification, chromosome 1p dele-tion, and additional chromosomal aberrations were notobserved. Microsatellite analysis of 16 chromosome 1pmarkers demonstrated the presence of replication errorsat the adjacent loci D1S496 and D1S197 only in R1 andexcluded the presence of small 1p deletions (data notshown).Neuroblastoma generally presents as a sporadic singlelesion. However, the occurrence of multiple primarytumors in young children has been described and couldunderline a genetic predisposition of this disease [1–3,5].Unlike other cases described in the literature [3], ourpatient developed the tumors at an older age and herdisease progressed rapidly. In Figure 2, we rep
*神经母细胞瘤是儿童最常见的颅外实体瘤,其分子和临床特征具有异质性。迄今为止,关于多灶性神经母细胞瘤的分子研究报道很少,这种肿瘤的表现模式约占2%,反映了这种肿瘤复杂的发病机制[1-3]。在此,我们报告一例双侧肾上腺同步神经母细胞瘤。我们的研究揭示了分子和细胞遗传学异质性的存在,并提示克隆进化可能发生在原发肿瘤之一。1995年6月,一名7岁女孩因腹痛住进gaslini儿童医院(意大利热那亚)。超声显示右肾上腺有圆形非均匀肿块(右),左肾上腺有小肿块(左)。尿儿茶酚胺排泄、血清乳酸脱氢酶和铁蛋白水平异常升高。两个肿瘤和几个淋巴结均被切除。组织病理学和临床评估诊断为双侧同步神经母细胞瘤,均为基质不良[1]。根据Shimada等人的研究,右侧肿瘤为未分化亚型,mkii高。该肿瘤形态不均匀,呈分化区(R1)和未分化区(R2)。L型肿瘤为分化亚型,MKI低。术后6个月肿瘤在腹膜后复发,患者接受了6个周期的化疗和放疗。14个月后,在远端淋巴结和右侧第9支发现多次复发。淋巴结转移(M)活检可用于分子研究。患者接受了积极的化疗,但于1997年因疾病进展而死亡。组织病理学数据显示,R1、R2和肿瘤区域具有不同的生物学特征。事实上,免疫组织化学分析显示R2中增殖标志物Ki-67的高水平表达。相反,在R1和L中,Ki-67阳性的细胞数量较少(图1,a - c)。三个地区的DNA指数均为1.00。比较基因组杂交(CGH)和荧光原位杂交(FISH)在R1、R2和M中显示了7号染色体的额外拷贝,但在L中没有(图1,d - 1)。未观察到MYCN基因扩增、染色体1p缺失和其他染色体畸变。对16个染色体1p标记的微卫星分析表明,仅在R1中存在邻近位点D1S496和D1S197的复制错误,并且排除了1p小缺失的存在(数据未显示)。神经母细胞瘤通常表现为散发性的单一病变。然而,幼儿多发原发性肿瘤的发生已被描述,并可能强调该疾病的遗传易感性[1 - 3,5]。与文献中描述的其他病例不同,我们的患者在年龄较大时出现肿瘤,并且病情进展迅速。在图2中,我们报道了肿瘤的生物学和分子特征以及可能的进化。总之,尽管可能存在其他解释,但我们的研究结果表明,该患者出现了两个独立的肿瘤(R和L),符合“多病灶”的概念。这一假设得到了7号染色体三体的支持,
{"title":"Molecular alterations in a case of bilateral adrenal neuroblastoma.","authors":"C. Lo Cunsolo, I. Casciano, C. Gambini, B. De Bernardi, G. Tonini, M. Romani","doi":"10.1002/MPO.1115","DOIUrl":"https://doi.org/10.1002/MPO.1115","url":null,"abstract":"*Neuroblastoma, the most common extracranial solidtumor of childhood, presents heterogeneous molecularand clinical characteristics. To date few molecular studieshave been reported for multifocal neuroblastoma, a modeof presentation of this tumor that occurrs in about 2% ofthe cases and reflects the complex pathogenesis of thisneoplasm [1–3]. Herein, we report a case of bilateraladrenal synchronous neuroblastoma. Our studies revealedthe presence of molecular and cytogenetic heterogeneityand suggest that a clonal evolution might have occurredin one of the primary tumors.A 7› year-old girl was admitted in June 1995 to theGaslini Children’s Hospital (Genova, Italy) for abdom-inal pain. Ultrasonography revealed a round nonhomo-geneous adrenal mass on the right (R) and a smalleradrenal mass on the left (L). Urinary catecholamineexcretion, serum lactate dehydrogenase, and ferritinlevels were abnormally elevated. Both tumors and severallymph nodes were resected. Histopathologic and clinicalevaluation led to a diagnosis of bilateral synchronousneuroblastoma, both stroma-poor [1]. The right-sidedtumor was of the undifferentiated subtype with high MKIaccording to Shimada et al. [4]. This tumor was morpho-logically heterogeneous and presented a differentiating(R1) and an undifferentiated (R2) area. The L tumor wasof the differentiating subtype, with low MKI. Six monthsafter surgery, the tumor recurred retroperitoneally, andthe patient was treated with six cycles of chemotherapyand irradiation. Fourteen months later, multiple relapseswere detected in distant lymph nodes and in the 9th rightrib. A biopsy from a lymph nodal metastasis (M) wasavailable for molecular studies. The patient was treatedwith aggressive chemotherapy, but died of diseaseprogression in 1997.Histopathologic data suggested that the R1, R2, and Ltumor areas had different biologic characteristics. In fact,immunohistochemical analysis showed a high level ofexpression of the proliferation marker Ki-67 in R2. Onthe contrary, in R1 and L an intermediate and a lownumber of cells were positive for Ki-67 (Fig. 1, A–C).The DNA index was 1.00 in all three areas. Comparativegenomic hybridization (CGH) and fluorescent in situhybridization (FISH) showed an additional copy ofchromosome 7 in R1, R2, and M, but not in L (Fig. 1,D–I). MYCN gene amplification, chromosome 1p dele-tion, and additional chromosomal aberrations were notobserved. Microsatellite analysis of 16 chromosome 1pmarkers demonstrated the presence of replication errorsat the adjacent loci D1S496 and D1S197 only in R1 andexcluded the presence of small 1p deletions (data notshown).Neuroblastoma generally presents as a sporadic singlelesion. However, the occurrence of multiple primarytumors in young children has been described and couldunderline a genetic predisposition of this disease [1–3,5].Unlike other cases described in the literature [3], ourpatient developed the tumors at an older age and herdisease progressed rapidly. In Figure 2, we rep","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"68 1","pages":"491-3"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90952751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Spontaneous nocturnal growth hormone secretion in children after medulloblastoma therapy. 成神经管细胞瘤治疗后儿童夜间自发生长激素分泌的变化。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1116
M. Marx, J. Beck, G. Grabenbauer, H. Dörr
{"title":"Spontaneous nocturnal growth hormone secretion in children after medulloblastoma therapy.","authors":"M. Marx, J. Beck, G. Grabenbauer, H. Dörr","doi":"10.1002/MPO.1116","DOIUrl":"https://doi.org/10.1002/MPO.1116","url":null,"abstract":"","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"80 1","pages":"494-6"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83516820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Art therapy as support for children with leukemia during painful procedures. 艺术疗法在痛苦的治疗过程中为白血病儿童提供支持。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1112
C. Favara‐Scacco, Giuseppina Smirne, Gino Schilirò, Andrea Di Cataldo
BACKGROUNDChildren with leukemia undergo painful procedures such as lumbar puncture and bone marrow aspiration. To overcome pain, certain units offer total anesthesia; others offer generic support; others offer no preparation at all. Since September, 1997, we have provided leukemic children with art therapy (AT), a nonverbal and creative modality that develops coping skills. Our goal is to prevent anxiety and fear during painful interventions as well as prolonged emotional distress.PROCEDUREWe treated 32 children aged 2-14 years. The modes of AT before, during, and after the punctures were as follows: clinical dialogue to calm children and help them cope with painful procedures; visual imagination to activate alternative thought processes and decrease the attention towards overwhelming reality and raise the peripheral sensitivity gate; medical play to clarify illness, eliminate doubts, and offer control over threatening reality; structured drawing to contain anxiety by offering a structured, predictable reality (the drawing) that was controllable by children; free drawing to allow children to externalize confusion and fears; and dramatization to help children accept and reconcile themselves to body changes.RESULTSChildren hospitalized before September, 1997, exhibited resistance and anxiety during and after painful procedures. By contrast, children provided with AT from the first hospitalization exhibited collaborative behavior. They or their parents asked for AT when the intervention had to be repeated. Parents declared themselves better able to manage the painful procedures when AT was offered.CONCLUSIONAT was shown to be a useful intervention that can prevent permanent trauma and support children and parents during intrusive interventions.
白血病患儿接受痛苦的手术,如腰椎穿刺和骨髓穿刺。为了克服疼痛,某些单位提供全身麻醉;其他提供通用支持;另一些则根本不提供任何准备。自1997年9月以来,我们为白血病儿童提供艺术疗法(AT),这是一种非语言和创造性的方式,可以培养应对技能。我们的目标是在痛苦的干预过程中防止焦虑和恐惧,以及长期的情绪困扰。我们治疗了32名2-14岁的儿童。穿刺前、穿刺中、穿刺后的AT模式为:临床对话,安抚患儿,帮助其应对穿刺过程的痛苦;视觉想象激活替代思维过程,减少对压倒性现实的关注,提高外围敏感门;医疗游戏澄清疾病,消除疑虑,并提供对威胁现实的控制;通过提供一个结构化的、可预测的、儿童可以控制的现实(绘画)来控制焦虑;自由绘画,让孩子外化困惑和恐惧;通过戏剧化来帮助孩子们接受和适应身体的变化。结果1997年9月前住院的患儿在疼痛手术中及术后均表现出抗拒和焦虑。相比之下,从第一次住院开始提供AT的儿童表现出合作行为。当必须重复干预时,他们或他们的父母要求AT。父母们声称,当接受了AT治疗后,他们能更好地应对痛苦的过程。结论干预是一种有效的干预措施,可以预防永久性创伤,并在侵入性干预中为儿童和家长提供支持。
{"title":"Art therapy as support for children with leukemia during painful procedures.","authors":"C. Favara‐Scacco, Giuseppina Smirne, Gino Schilirò, Andrea Di Cataldo","doi":"10.1002/MPO.1112","DOIUrl":"https://doi.org/10.1002/MPO.1112","url":null,"abstract":"BACKGROUND\u0000Children with leukemia undergo painful procedures such as lumbar puncture and bone marrow aspiration. To overcome pain, certain units offer total anesthesia; others offer generic support; others offer no preparation at all. Since September, 1997, we have provided leukemic children with art therapy (AT), a nonverbal and creative modality that develops coping skills. Our goal is to prevent anxiety and fear during painful interventions as well as prolonged emotional distress.\u0000\u0000\u0000PROCEDURE\u0000We treated 32 children aged 2-14 years. The modes of AT before, during, and after the punctures were as follows: clinical dialogue to calm children and help them cope with painful procedures; visual imagination to activate alternative thought processes and decrease the attention towards overwhelming reality and raise the peripheral sensitivity gate; medical play to clarify illness, eliminate doubts, and offer control over threatening reality; structured drawing to contain anxiety by offering a structured, predictable reality (the drawing) that was controllable by children; free drawing to allow children to externalize confusion and fears; and dramatization to help children accept and reconcile themselves to body changes.\u0000\u0000\u0000RESULTS\u0000Children hospitalized before September, 1997, exhibited resistance and anxiety during and after painful procedures. By contrast, children provided with AT from the first hospitalization exhibited collaborative behavior. They or their parents asked for AT when the intervention had to be repeated. Parents declared themselves better able to manage the painful procedures when AT was offered.\u0000\u0000\u0000CONCLUSION\u0000AT was shown to be a useful intervention that can prevent permanent trauma and support children and parents during intrusive interventions.","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"2 1","pages":"474-80"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85594460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 146
Rapid deterioration of a newborn with congenital spinal cord astrocytoma. 新生儿先天性脊髓星形细胞瘤的快速恶化。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1118
C. Colby, P. Rozance, T. Goodwin, P. Fisher
{"title":"Rapid deterioration of a newborn with congenital spinal cord astrocytoma.","authors":"C. Colby, P. Rozance, T. Goodwin, P. Fisher","doi":"10.1002/MPO.1118","DOIUrl":"https://doi.org/10.1002/MPO.1118","url":null,"abstract":"","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"59 1","pages":"500-2"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91007522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection. 急性淋巴细胞白血病缓解期儿童肝功能障碍:与肝炎感染的关系。
Pub Date : 2001-04-01 DOI: 10.1002/MPO.1111
H. Meir, I. Balawi, H. Nayel, H. E. El Karaksy, A. El Haddad
BACKGROUNDViral hepatitis is a cause of hepatic dysfunction in children with ALL in remission during maintenance therapy is debated. The aims of the current study were (1) to explore the incidence of hepatic dysfunction in a group of children (Egyptian and Saudi) with ALL under maintenance therapy, (2) to study the prevalence of hepatitis B (HBV) and/or C (HCV) infection and their contributions to chronic liver disease that might be induced by maintenance therapy.PROCEDUREThe current study included 105 children with ALL (54 Egyptian and 51 Saudi). All eligible patients had been on maintenance therapy for at least 12 months and all had serial assessments of liver function. These included determination of total bilirubin, AST, ALT, and alkaline phosphatase. Markers for HBV and HCV including HBsAg, anti-HBC, and anti-HCV and for some patients HCV RNA by PCR were studied. Percutaneous liver biopsy was performed for a group of children.RESULTSThe prevalence of hepatitis infection (HBV and/or HCV) among Egyptian children was found to be high (43/54-80%). Only five Saudi children had evidence of exposure to HBV (5/51-9.8%), P<0.0001. During the period of study, 22 Egyptian patients vs. four Saudi patients (41 vs. 7.8%, P<0.0001) experienced at least one episode of elevation of liver enzymes, three times the upper limit of normal or more. Twenty-six of the 48 patients (54%) with HBV and/or HCV infection had episodes of elevated liver enzymes, while there was no occurrence among the patients negative for HBV and HCV. In patients with HBV infection, the presence of HBsAg was strongly associated (100%) with elevated liver enzymes. Histopathologic examination of liver biopsies obtained from 35 patients revealed that all five patients negative for HBV and HCV had normal liver biopsies in spite of being under maintenance therapy.CONCLUSIONIn children undergoing treatment for ALL, elevations in liver enzymes may be primarily due to hepatitis viruses. However, maintenance therapy using known hepatotoxic drugs, may have additive deleterious effects. Liver enzymes are normalized in affected patients when maintenance therapy is temporarily suspended.
背景:病毒性肝炎是否是ALL患儿维持治疗期间缓解期肝功能障碍的一个原因一直存在争议。本研究的目的是:(1)探讨一组接受维持治疗的ALL患儿(埃及和沙特)肝功能障碍的发生率,(2)研究乙型肝炎(HBV)和/或丙型肝炎(HCV)感染的患病率及其对维持治疗可能引起的慢性肝病的影响。目前的研究包括105名ALL患儿(54名埃及患儿和51名沙特患儿)。所有符合条件的患者都接受了至少12个月的维持治疗,并进行了肝功能的系列评估。这些包括测定总胆红素、AST、ALT和碱性磷酸酶。研究了HBV和HCV的标志物,包括HBsAg、anti-HBC和anti-HCV,以及部分患者的HCV RNA PCR检测。对一组儿童进行了经皮肝活检。结果埃及儿童肝炎(HBV和/或HCV)感染率较高(43/54 ~ 80%)。只有5名沙特儿童有HBV暴露的证据(5/51-9.8%),P<0.0001。在研究期间,22名埃及患者和4名沙特患者(41名vs. 7.8%, P<0.0001)经历了至少一次肝酶升高,是正常上限的三倍或更高。48例HBV和/或HCV感染患者中有26例(54%)出现肝酶升高,而HBV和HCV阴性患者中没有出现肝酶升高。在HBV感染患者中,HBsAg的存在与肝酶升高密切相关(100%)。对35例患者的肝活检组织病理学检查显示,尽管接受了维持治疗,但所有5例HBV和HCV阴性患者的肝活检均正常。结论在接受ALL治疗的儿童中,肝酶升高可能主要是由肝炎病毒引起的。然而,使用已知的肝毒性药物进行维持治疗,可能会产生附加的有害作用。当暂时停止维持治疗时,受影响患者的肝酶恢复正常。
{"title":"Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection.","authors":"H. Meir, I. Balawi, H. Nayel, H. E. El Karaksy, A. El Haddad","doi":"10.1002/MPO.1111","DOIUrl":"https://doi.org/10.1002/MPO.1111","url":null,"abstract":"BACKGROUND\u0000Viral hepatitis is a cause of hepatic dysfunction in children with ALL in remission during maintenance therapy is debated. The aims of the current study were (1) to explore the incidence of hepatic dysfunction in a group of children (Egyptian and Saudi) with ALL under maintenance therapy, (2) to study the prevalence of hepatitis B (HBV) and/or C (HCV) infection and their contributions to chronic liver disease that might be induced by maintenance therapy.\u0000\u0000\u0000PROCEDURE\u0000The current study included 105 children with ALL (54 Egyptian and 51 Saudi). All eligible patients had been on maintenance therapy for at least 12 months and all had serial assessments of liver function. These included determination of total bilirubin, AST, ALT, and alkaline phosphatase. Markers for HBV and HCV including HBsAg, anti-HBC, and anti-HCV and for some patients HCV RNA by PCR were studied. Percutaneous liver biopsy was performed for a group of children.\u0000\u0000\u0000RESULTS\u0000The prevalence of hepatitis infection (HBV and/or HCV) among Egyptian children was found to be high (43/54-80%). Only five Saudi children had evidence of exposure to HBV (5/51-9.8%), P<0.0001. During the period of study, 22 Egyptian patients vs. four Saudi patients (41 vs. 7.8%, P<0.0001) experienced at least one episode of elevation of liver enzymes, three times the upper limit of normal or more. Twenty-six of the 48 patients (54%) with HBV and/or HCV infection had episodes of elevated liver enzymes, while there was no occurrence among the patients negative for HBV and HCV. In patients with HBV infection, the presence of HBsAg was strongly associated (100%) with elevated liver enzymes. Histopathologic examination of liver biopsies obtained from 35 patients revealed that all five patients negative for HBV and HCV had normal liver biopsies in spite of being under maintenance therapy.\u0000\u0000\u0000CONCLUSION\u0000In children undergoing treatment for ALL, elevations in liver enzymes may be primarily due to hepatitis viruses. However, maintenance therapy using known hepatotoxic drugs, may have additive deleterious effects. Liver enzymes are normalized in affected patients when maintenance therapy is temporarily suspended.","PeriodicalId":18531,"journal":{"name":"Medical and pediatric oncology","volume":"259 1","pages":"469-73"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75212616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
期刊
Medical and pediatric oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1